Zacks
Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally?
📈
AI Sentiment
Highly Positive
8/10
- Home
- ILMN
ILMN
Illumina Inc.
as of 03-12-2026 3:43pm EST
$116.78
$5.22
-4.28%
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 20.4B | IPO Year: | 2000 |
| Target Price: | $124.24 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Hold | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 5.45 | EPS Growth: | 170.87 |
| 52 Week Low/High: | $68.70 - $155.53 | Next Earning Date: | 04-30-2026 |
| Revenue: | $4,343,000,000 | Revenue Growth: | -0.66% |
| Revenue Growth (this year): | 6.52% | Revenue Growth (next year): | 5.49% |
| P/E Ratio: | 22.26 | Index: | N/A |
| Free Cash Flow: | 931.0M | FCF Growth: | +31.31% |
Stock Insider Trading Activity of Illumina Inc. (ILMN)
Davies Scott M
Sell
Chief Legal Officer
ILMN Feb 20, 2026
Avg Cost/Share
$116.18
Shares
1,336
Total Value
$155,216.48
Owned After
16,334
SEC Form 4
Leckman Patricia
Sell
SVP, Chief People Officer
ILMN Feb 18, 2026
Avg Cost/Share
$116.18
Shares
2,370
Total Value
$275,346.60
Owned After
16,321
SEC Form 4
Gottlieb Scott
Buy
Director
ILMN Feb 9, 2026
Avg Cost/Share
$117.81
Shares
200
Total Value
$23,562.00
Owned After
12,723
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Davies Scott M | ILMN | Chief Legal Officer | Feb 20, 2026 | Sell | $116.18 | 1,336 | $155,216.48 | 16,334 | |
| Leckman Patricia | ILMN | SVP, Chief People Officer | Feb 18, 2026 | Sell | $116.18 | 2,370 | $275,346.60 | 16,321 | |
| Gottlieb Scott | ILMN | Director | Feb 9, 2026 | Buy | $117.81 | 200 | $23,562.00 | 12,723 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 5, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLFeb 5, 2026 · 100% conf.
AI Prediction SELL
1D
-2.52%
$130.25
Act: -10.40%
5D
-6.62%
$124.77
Act: -14.35%
20D
-8.81%
$121.84
Act: -6.93%
Price: $133.61 Prob +5D: 0% AUC: 1.000
0001110803-26-000018
ilmn-202602050001110803FALSE2/5/202600011108032026-02-052026-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 Form 8-K Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026
Illumina, Inc. (Exact name of registrant as specified in its charter)
001-35406 (Commission File Number) Delaware 33-0804655 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
5200 Illumina Way, San Diego, CA 92122 (Address of principal executive offices) (Zip code)
(858) 202-4500 (Registrant’s telephone number, including area code)
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueILMNThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits
SIGNATURES
Exhibit Index
Table of Contents
Item 2.02 Results of Operations and Financial Condition.
On February 5, 2026, Illumina, Inc. (the “Company”) issued a press release announcing financial results for the fourth quarter and fiscal year ended December 28, 2025. The full text of the Company’s press release is attached hereto as Exhibit 99.1.
The information furnished pursuant to this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Table of Contents
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release dated February 5, 2026, announcing Illumina, Inc.’s financial results for the fourth quarter and fiscal year ended December 28, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ILLUMINA, INC.
Date:February 5, 2026By: /s/ ANKUR DHINGRA
Name:Ankur Dhingra Title:Chief Financial Officer
Table of Contents
Exhibit Index
Exhibit NumberDescription 99.1 Press release dated February 5, 2026 announcing Illumina, Inc.’s financial results for the fourth quarter and fiscal year ended December 28, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
2025 Q4 Q4 2025 Earnings
8-K SELL Jan 13, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLJan 13, 2026 · 100% conf.
AI Prediction SELL
1D
-2.52%
$130.25
Act: -10.40%
5D
-6.62%
$124.77
Act: -14.35%
20D
-8.81%
$121.84
Act: -6.93%
Price: $133.61 Prob +5D: 0% AUC: 1.000
0001110803-26-000009
ilmn-202601130001110803FALSEJanuary 13, 202600011108032026-01-132026-01-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 Form 8-K Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2026
Illumina, Inc. (Exact name of registrant as specified in its charter)
001-35406 (Commission File Number) Delaware 33-0804655 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
5200 Illumina Way, San Diego, CA 92122 (Address of principal executive offices) (Zip code)
(858) 202-4500 (Registrant’s telephone number, including area code)
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueILMNThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits
SIGNATURES
Exhibit Index
Table of Contents
Item 2.02 Results of Operations and Financial Condition.
On January 13, 2026, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, Illumina, Inc. (the "Company") issued a press release regarding the Company's unaudited preliminary financial results for the fourth quarter and fiscal year ended December 28, 2025. The webcast is accessible through the Investor Relations section of the Company’s website and will remain available for at least 30 days following. Pursuant to General Instruction F to Form 8-K, a copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 2.02 by this reference.
The information furnished pursuant to this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Table of Contents
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release dated January 13, 2026, announcing Illumina, Inc.’s preliminary unaudited financial results for the fourth quarter and fiscal year ended December 28, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ILLUMINA, INC.
Date:January 13, 2026 By:/s/ ANKUR DHINGRA
Name:Ankur Dhingra Title:Chief Financial Officer
Table of Contents
Exhibit Index
Exhibit NumberDescription 99.1 Press release dated January 13, 2026, announcing Illumina, Inc.’s preliminary unaudited financial results for the fourth quarter and fiscal year ended December 28, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
2025 Q3 Q3 2025 Earnings
8-K Oct 30, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 30, 2025
0001110803-25-000071
ilmn-202510300001110803FALSE00011108032025-10-302025-10-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 Form 8-K Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2025
Illumina, Inc. (Exact name of registrant as specified in its charter)
001-35406 (Commission File Number) Delaware 33-0804655 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
5200 Illumina Way, San Diego, CA 92122 (Address of principal executive offices) (Zip code)
(858) 202-4500 (Registrant’s telephone number, including area code)
N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueILMNThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits
SIGNATURES
Exhibit Index
Table of Contents
Item 2.02 Results of Operations and Financial Condition.
On October 30, 2025, Illumina, Inc. (the “Company”) issued a press release announcing financial results for the third quarter ended September 28, 2025. The full text of the Company’s press release is attached hereto as Exhibit 99.1.
The information furnished pursuant to this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Table of Contents
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press release dated October 30, 2025, announcing Illumina, Inc.’s financial results for the third quarter ended September 28, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ILLUMINA, INC.
Date:October 30, 2025By: /s/ ANKUR DHINGRA
Name:Ankur Dhingra Title:Chief Financial Officer
Table of Contents
Exhibit Index
Exhibit NumberDescription 99.1 Press release dated October 30, 2025 announcing Illumina, Inc.’s financial results for the third quarter ended September 28, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Latest Illumina Inc. News
ILMN Breaking Stock News: Dive into ILMN Ticker-Specific Updates for Smart Investing
Simply Wall St.
Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions
📊
AI Sentiment
Positive
7/10
Compare ILMN vs Leading Stocks
See how ILMN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ILMN Illumina Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.